COVID‐19 pneumonia in a pediatric sickle cell patient requiring red blood cell exchange

Patients with sickle cell disease are already at high risk for respiratory complications, which SARS‐CoV‐2 can rapidly worsen. The case emphasizes the importance of efficiently maximizing standard therapies in sickle cell patients with COVID‐19.

Detalles Bibliográficos
Autores principales: Walker, Shannon C., Murphy, Meghan L., Hendricks, Hope, Dulek, Daniel E., Volanakis, Emmanuel J., Borinstein, Scott C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7981740/
https://www.ncbi.nlm.nih.gov/pubmed/33768846
http://dx.doi.org/10.1002/ccr3.3774

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7981740/
https://www.ncbi.nlm.nih.gov/pubmed/33768846
http://dx.doi.org/10.1002/ccr3.3774

Ejemplares similares